Novel plasmid-mediated beta-lactamase in members of the family Enterobacteriaceae from Ohio
- 1 August 1986
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 30 (2) , 220-224
- https://doi.org/10.1128/aac.30.2.220
Abstract
Epidemiologic studies of plasmid-mediated resistance at the Cleveland Veterans Administration Medical Center revealed that related plasmids had disseminated among members of the family Enterobacteriaceae. We studied the beta-lactamases encoded by these plasmids in Escherichia coli C600 transformants or transconjugants. Substrate and inhibition profiles of the enzymes determined by two of these plasmids suggested an activity resembling TEM-1; however, isoelectric focusing revealed a pI of 7.0. These two plasmids were originally found in a Serratia marcescens (pDS076) and an Enterobacter cloacae (pDS075) strain isolated from the same sink in the medical intensive care unit and later, in an Enterobacter cloacae (pDS142 identical to pDS076) isolate colonizing a patient in the same unit. The plasmids also carried the aminoglycoside resistance determinant, 2"-aminoglycoside nucleotidyl transferase. A 2-kilobase AvaI restriction endonuclease digestion fragment of pSD075 known to carry the beta-lactamase determinant was used as a molecular probe. This probe did not recognize sequences of any plasmid-mediated beta-lactamase tested including the recently described determinants ROB-1, TLE-1, and OXA-4-7. A TEM-1 probe derived from the 0.7-kilobase PstI-EcoRI fragment of pBR322 failed to recognize the new beta-lactamase gene. Four additional Enterobacter cloacae and two Enterobacter aerogenes strains isolated in Columbus, Ohio, have been shown to produce a pI 7.0 beta-lactamase and to carry plasmids recognized by the 2-kilobase probe. These data suggest dissemination of a novel plasmid-mediated beta-lactamase among members of the family Enterobacteriaceae in Ohio and demonstrate the development and utility of a molecular probe for the new determinant. We suggest that the novel beta-lactamase be named OHIO-1.This publication has 21 references indexed in Scilit:
- Detection of specific sequences among DNA fragments separated by gel electrophoresisPublished by Elsevier ,2006
- A gene probe for TEM type beta-lactamasesAntimicrobial Agents and Chemotherapy, 1985
- Genetic and biochemical properties of AER-1, a novel carbenicillin-hydrolyzing beta-lactamase from Aeromonas hydrophilaAntimicrobial Agents and Chemotherapy, 1985
- Characterization of the plasmid-mediated β-lactamase in Branhamella catarrhalis, with special reference to substrate affinityJournal of Antimicrobial Chemotherapy, 1985
- Variability in DNA Sequence of Closely Related Nosocomial Gentamicin-Resistant PlasmidsThe Journal of Infectious Diseases, 1983
- Comparison of polyacrylamide and agarose gel thin-layer isoelectric focusing for the characterization of beta-lactamasesAntimicrobial Agents and Chemotherapy, 1983
- AMPICILLIN TREATMENT FAILURE OF APPARENTLY β-LACTAMASE-NEGATIVE HAEMOPHILUS INFLUENZAE TYPE b MENINGITIS DUE TO NOVEL β-LACTAMASEThe Lancet, 1981
- The distribution of β-lactamase genes on plasmids found in PseudomonasPlasmid, 1979
- The Use of Analytical Isoelectric Focusing for Detection and Identification of -LactamasesJournal of General Microbiology, 1975
- Computerized microacidimetric determination of β lactamase Michaelis—Menten constantsFEBS Letters, 1973